NCT06980506View on ClinicalTrials.gov

MNPR-101-DFO*-89Zr Expanded Access Program (EAP) for Patients With Solid Tumor Cancer

AVAILABLEEXPANDED_ACCESS
Timeline

Start Date

Not specified

Conditions
CancerSolid TumorSolid Tumor, Adult
Interventions
DIAGNOSTIC_TEST

MNPR-101-DFO*-89Zr

MNPR-101-DFO\*-89Zr is an antibody radionuclide conjugate intended to image solid tumors expressing uPAR.

Trial Locations (1)

77042

AVAILABLE

Excel Diagnostics & Nuclear Oncology Center, Houston

Sponsors
All Listed Sponsors
lead

Monopar Therapeutics

INDUSTRY

NCT06980506 - MNPR-101-DFO*-89Zr Expanded Access Program (EAP) for Patients With Solid Tumor Cancer | Biotech Hunter | Biotech Hunter